Press Room

Press Room

Press release

Population Council and Duchesnay Announce New International License Agreement for ANNOVERA®

Read more >
Press release

Duchesnay Inc. is seeking Health Canada's approval for ospemifene for the treatment of moderate to severe dyspareunia and vaginal dryness, symptoms of vulvar and vaginal atrophy (VVA), a component of genitourinary syndrome of menopause (GSM)

Read more >
Press release

Prevegyne®, the ONLY 6-day vaginal tablet treatment for non-specific vaginitis/bacterial vaginosis, now with the convenience of a vaginal applicator

Read more >
Press release

Duchesnay Donates $18,500 to Moisson Laurentides Food Bank

Read more >